Scribd Logo
Загрузить

Добро пожаловать в Scribd!

  • Pharmaceutical

    Загружено:

    ankush_kohli
    10 просмотров1 страница
    India's largest selling drug products are antibiotics, but the fastest growing are diabetes, Cardiovascular and Central Nervous System treatments. India's pharmaceutical (world's 2nd largest by volume) About 17% growth in 2009-10.

    Исходное описание:

    Авторское право

    © Attribution Non-Commercial (BY-NC)

    Доступные форматы

    DOC, PDF, TXT или читайте онлайн в Scribd

    Этот документ был вам полезен?

    Это неприемлемый материал?

    Пожаловаться на этот документ
    India's largest selling drug products are antibiotics, but the fastest growing are diabetes, Cardiovascular and Central Nervous System treatments. India's pharmaceutical (world's 2nd largest by volume) About 17% growth in 2009-10.

    Авторское право:

    Attribution Non-Commercial (BY-NC)
    Скачайте в формате DOC, PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    10 просмотров1 страница

    Pharmaceutical

    Загружено:

    ankush_kohli
    India's largest selling drug products are antibiotics, but the fastest growing are diabetes, Cardiovascular and Central Nervous System treatments. India's pharmaceutical (world's 2nd largest by volume) About 17% growth in 2009-10.

    Авторское право:

    Attribution Non-Commercial (BY-NC)
    Скачайте в формате DOC, PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    из 1

    Date: 17-01-11

    Assignment No. 1
    Industry: Indian Pharmaceutical (World’s 2nd largest by volume)

    About 17% growth in 2009-10.

    Total Companies: 250 to 300 Approx.

    Bases for Analysis: India’s largest selling drug products are Antibiotics, but the fastest growing are
    Diabetes, Cardiovascular and Central Nervous System treatments.

    Branded drugs are: Corex, Insulin, Voveran, Becosules(vt. B complex & vt. C), Taxim, Asthalin,
    Sporidex, Digene, Betnesol and Althrocin.

    Market Leader: Ranbaxy – Rs. 4243 Cr.

    Market Challenger: Cipla – Rs. 2055 Cr.

    Dr. Reddy’s – Rs. 1839 Cr.

    Nicholas Piramal – Rs. 1440 Cr.

    GSK – Rs. 1242 Cr.

    Cadila – Rs. 1172 Cr.

    Market Follower: Pfizer – Rs. 594 Cr.

    Morepen – Rs. 570 Cr.

    Matrix Lab – Rs. 557 Cr.

    Biocon Ltd – Rs. 537 Cr.

    Glenmark Pharma – Rs. 382 Cr.

    Market Nicher: Li Taka Pharma – Rs. 61 Cr.

    Venkat Pharma – Rs. 52 Cr.

    Ankur Drugs – Rs. 61 Cr.

    Themis Medicare – Rs. 77 Cr.

    Others: Dabur Pharma – 215 Cr.

    Zandu Pharma – Rs. 124 Cr.

    Surya – Rs. 173 Cr.

    Submitted to: Dr. Rachna Mahajan

    Submitted by: Robin Ganjoo – MBA-31-2010

    Вам также может понравиться